NewLake Capital Partners CEO Anthony Coniglio will speak at the IgniteIt Cannabis Capital and Policy Summit 2026 on November 18, discussing changes in cannabis lending and capital raising. The panel, moderated by Jeanne Sullivan of Arcview Ventures, will explore evolving lender requirements and considerations for cannabis businesses seeking funding. NewLake is a real estate investment trust providing capital to state-licensed cannabis operators through sale-leaseback and build-to-suit projects, owning 37 properties including cultivation and dispensary facilities. This participation highlights NewLake's role in shaping cannabis industry finance amid regulatory and market shifts.
NewLake Capital Partners CEO Anthony Coniglio's upcoming speech is noted here with Pluang's Real Estate sector data as context. For readers following Real Estate, as of Nov 10, 2026 20:41 WIB, 20 of 47 US Real Estate stocks rose and 22 fell on Pluang. Notable prices include Digital Realty Trust at USD 178.69 with a -0.78% change and a typical hold time of 96 days, Macerich Company at USD 25.12 with a -0.67% change and 26 days hold time, and ARMOUR Residential REIT at USD 12.70 with a -0.55% change, 141 days hold time, and 9% sell versus 91% buy order activity.
project44 has partnered with Snowflake to enhance supply chain decision-making through Mo, an AI-powered supply chain analyst. Mo uses project44's extensive logistics data and Snowflake Cortex AI to provide accurate, consistent answers to complex sup...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
